How to protect cannabis IP
20-04-2021
Amyris facing $881m lawsuit over claims it broke contract
11-09-2020
elroi / Shutterstock.com
A New York federal court has denied biotechnology company Amyris’ bid for arbitration in an $881 million trade secrets and patent infringement dispute with cannabis firm Lavvan.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US District Court for the Southern District of New York, Lavvan, Amyris, cannabinoid, arbitration, patent infringement
